Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.2 million.

  • Catheter Precision's Free Cash Flow rose 2055.64% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 1585.73%. This contributed to the annual value of -$9.4 million for FY2024, which is 5473.79% up from last year.
  • According to the latest figures from Q3 2025, Catheter Precision's Free Cash Flow is -$2.2 million, which was up 2055.64% from -$2.3 million recorded in Q2 2025.
  • Catheter Precision's 5-year Free Cash Flow high stood at -$1.7 million for Q2 2024, and its period low was -$12.1 million during Q1 2023.
  • Moreover, its 5-year median value for Free Cash Flow was -$3.1 million (2022), whereas its average is -$4.6 million.
  • Data for Catheter Precision's Free Cash Flow shows a peak YoY increase of 8375.52% (in 2024) and a maximum YoY decrease of 5170.42% (in 2024) over the last 5 years.
  • Catheter Precision's Free Cash Flow (Quarter) stood at -$5.8 million in 2021, then surged by 46.56% to -$3.1 million in 2022, then surged by 37.96% to -$1.9 million in 2023, then crashed by 51.7% to -$2.9 million in 2024, then increased by 23.99% to -$2.2 million in 2025.
  • Its Free Cash Flow was -$2.2 million in Q3 2025, compared to -$2.3 million in Q2 2025 and -$2.3 million in Q1 2025.